Kirsten Lund Jurgensen

Executive Vice President Head of Supply & Technology Unit at UCB S. A.

Kirsten Lund Jurgensen

Kirsten Lund Jurgensen

Executive Vice President Head of Supply & Technology Unit at UCB S. A.

Career Highlights

Pfizer Global Supply

RelSci Relationships


Number of Boards






Contact Data
Trying to get in touch with Kirsten Lund Jurgensen? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
RelSci Relationships are individuals Kirsten Lund Jurgensen likely has professional access to. A relationship does not necessarily indicate a personal connection.

President at The Pfizer Foundation, Inc.

Relationship likelihood: Strong

Executive Director at Pfizer, Inc.

Relationship likelihood: Strong

Former President & General Manager of Emerging Markets at Pfizer, Inc.

Relationship likelihood: Strong

Group President-Chief Business Officer at Pfizer, Inc.

Relationship likelihood: Strong

Executive Vice President, Corporate Affairs & Market Access at Celgene Corp.

Relationship likelihood: Strong

Operating Executive, Global Healthcare Group at The Carlyle Group, Inc.

Relationship likelihood: Strong

Vice Chairman & President at The New York Botanical Garden

Relationship likelihood: Strong

Former President & Chief Executive Officer at Africare, Inc.

Relationship likelihood: Strong

Chairman, Chief Executive & Operating Officer at Pfizer, Inc.

Relationship likelihood: Strong

Former General Manager at Pfizer, Inc.

Relationship likelihood: Strong

Paths to Kirsten Lund Jurgensen
Potential Connections via
Relationship Science
Kirsten Lund Jurgensen
Executive Vice President Head of Supply & Technology Unit at UCB S. A.

The University of Freiburg, sometimes referred to with its full title, the Albert Ludwig University.

Career History
2016 - 2018

Pfizer Global Supply, part of Pfizer Inc., is a company headquartered in Ringaskiddy, Ireland. The firm manufactures and supplies pharmaceutical products.

Executive Vice President & President, Pfizer Global Supply
1999 - 2018

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Vice President
Prior - 1999

Smithkline Beecham Corp. engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products for customers in the United States. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. The company also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.

Boards & Committees
2008 - Current

Over the last five years, the Pfizer Foundation and Pfizer Worldwide Philanthropy department has developed platform focused on investing the full range of the company's resources — people, skills, expertise and funding — to broaden access to medicines and strengthen healthcare delivery for underserved people around the world. The new philanthropy platform, Pfizer Investments in Health, offers a more coordinated approach to contribute to society beyond medicines, centered around developing stronger relationships with their partners (grantees, field experts, etc.) and including cash grants, capacity building/technical assistance, product, skilled volunteers and stronger networking. This has resulted in mutual benefits for Pfizer and for its philanthropic partners. Introduction The Pfizer Foundation, the philanthropic arm of the world-leading pharmaceutical company, Pfizer Inc, is committed to addressing global health needs through community programs that also leverage its corporate resources and connections. Pfizer had successfully implemented international and smaller scale domestic HIV/AIDS programs, but recognized the need for greater national attention. In 2002, the Pfizer Foundation developed the Southern HIV/AIDS Prevention Initiative (SHAPI) in reaction to the growing HIV/AIDS epidemic in the southern United States. HIV/AIDS rates were still alarmingly high and growing, especially in the U.S. South. SHAPI, a three-year program from 2003 to 2006, provided more than $3 million in program investments and $3 million in capacity-building opportunities. To further develop the program and assist in its strategic planning and implementation the Foundation engaged TCC Group in 2002. Developing Focus and Goals In response to TCC Group's research and facilitated discussions with stakeholders, the Pfizer Foundation focused SHAPI on prevention programs in small to mid-size AIDS Service Organizations (ASOs), particularly those working with minorities and women. With TCC's help, the Foundation developed a clear set of goals for SHAPI. The core strategy focused on building relationships and supporting a targeted number of organizations, and included investments focused on direct services in local prevention and education programs and additional investments designed to create longer lasting impact through organizational capacity building and regional networking opportunities. Together, TCC and the Pfizer Foundation selected 23 grantees and 39 additional finalists. Grantees were provided annual grants of up to $50,000 for prevention programs, and all grantees and finalists were provided with opportunities to improve organizational effectiveness and be a part of the SHAPI network. TCC managed the overall initiative and worked closely with grantees to achieve the SHAPI goals of capacity building and networking. Opportunities Beyond the Grants In order to offer grantees tailored capacity building opportunities, TCC Group developed a new, comprehensive assessment tool for nonprofit organizations that was based on best practices in the field and tested by leading ASOs (now further developed, available on-line and called the Core Capacity Assessment Tool (CCAT)). Using the CCAT, TCC identified target areas for capacity building in each participating organization as well as cross-cutting needs for clusters of organizations. Each SHAPI grantee was offered annual customized capacity building recommendations and funding support (which often was nearly equal to their program grant) as well as general opportunities, such as board development, peer mentoring, software and technology training, financial management, and evaluation technical assistance. In addition, TCC worked with the Foundation to provide networking opportunities to the SHAPI grantees and finalists, such as training sessions, teleconferences, and peer exchange. In particular, the Pfizer Foundation sponsored its SHAPI partners to attend the annual United States Conference on AIDS and hosted its own annual HIV/AIDS prevention conferences focused on HIV/AIDS prevention and capacity building needs identified throughout the year. During these networking opportunities, the Pfizer Foundation invited and introduced Pfizer Inc's HIV Community Liaisons (HCLs) to SHAPI partners to be able to foster more localized relationships with Pfizer Inc and to provide access to Pfizer Inc's local resources, such as training materials, mini-grants/sponsorships and volunteers. Through these networking opportunities, grantees and finalists shared ideas, information, and inspiration. "Long after Pfizer's funding relationship with [us] has concluded, the skills and expertise culled from these capacity-building efforts will continue to make [us] a trusted and well-respected organization." – NC Grantee

Member, Board of Directors

The National Association of Manufacturers (NAM) is the largest manufacturing association in the United States, representing small and large manufacturers in every industrial sector and in all 50 states. Manufacturing employs nearly 12 million men and women, contributes more than $1.8 trillion to the U.S. economy annually, has the largest economic impact of any major sector and accounts for two-thirds of private-sector research and development. The NAM is the powerful voice of the manufacturing community and the leading advocate for a policy agenda that helps manufacturers compete in the global economy and create jobs across the United States.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$250 - $499

ACCION International provides microcredit and financial support services. Its services include investments and client education. The company was founded by Joseph Blatchford in 1961 and is headquartered in Cambridge, MA.

Political Donations
Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Kirsten Lund Jurgensen. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Kirsten Lund Jurgensen's profile does not indicate a business or promotional relationship of any kind between RelSci and Kirsten Lund Jurgensen.